Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25 - CD4+ regulatory T cells

Journal of Immunology

Volumn 177, Issue 11, 2006, Pages 7634-7644

  Sun, Jia Bin ^a   Raghavan, Sukanya ^a   Sjöling, Åsa ^a   Lundin, Samuel ^a   Holmgren, Jan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CHOLERA TOXIN B SUBUNIT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; ISOLEUCYLSERYLGLUTAMINYLALANYLVALYLHISTIDYLALANYLALANYLHISTIDYLALANYLGLUTAMYLISOLEUCYLASPARAGINYLGLUTAMYLALANYLGLYCYLARGININE; MONOCLONAL ANTIBODY; OVALBUMIN; PEPTIDE DERIVATIVE; RAG1 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL SPECIFICITY; CONJUGATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; EFFECTOR CELL; FEMALE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLEEN; T LYMPHOCYTE SUBPOPULATION;

EID: 33751567891     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.11.7634     Document Type: Article

References (40)

1. Mowat, A. M., A. M. Faria, and H. L. Weiner. 2005. Oral tolerance: Physiological basis and clinical applications. In: Mucosal Immunology, Vol. 1, 3rd Ed. J. Mestecky, M. E. Lamm, W. Strober, J. Bienenstock, J. R. McGhee, and L. Mayer, eds. Elsevier, Amsterdam, pp. 487-537.
2. Holmgren, J., and C. Czerkinsky. 2005. Mucosal immunity and vaccines. Nat. Med. 11: 45-53.
3. Whitacre, C. C., I. E. Gienapp, C. G. Orosz, and D. M. Bitar. 1991. Oral tolerance in experimental autoimmune encephalomyelitis: III. Evidence for clonal anergy. J. Immunol. 147: 2155-2163.
4. + T cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature 389: 737-742.
5. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162: 5317-5326.
6. +CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 167: 188-195.
7. + regulatory T cells by oral antigen administration. J. Immunol. 167: 4245-4253.
8. + regulatory T cells in Peyer's patches. Annu. NY Acad. Sci. 1029: 366-370.
9. Shevach, E. M. 2000. Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 18: 423-449.
10. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22: 531-562.
11. - cells to develop suppressive activity: the role of IL-2, TGF-β, and IL-10. J. Immunol. 172: 5213-5221.
12. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192: 295-302.
13. Klein, L., K. Khazaie, and H. von Boehmer. 2003. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA 100: 8886-8891.
14. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
15. + regulatory T cells. Int. Immunol. 16: 1643-1656.
16. Fontenot, J. D., J. P. Rasmussen, L. M. Williams, J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 22: 329-341.
17. Sun, J.-B., J. Holmgren, and C. Czerkinsky. 1994. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci. USA 91: 10795-10799.
18. Sun, J.-B., C. Rask, T. Olsson, J. Holmgren, and C. Czerkinsky. 1996. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc. Natl. Acad. Sci. USA 93: 7196-7201.
19. 1 secreting cells and suppressing chemokine expression. Int. Immunol. 12: 1449-1457.
20. Bergerot, I., C. Ploix, J. Petersen, V. Moulin, C. Rask, N. Fabien, M. Lindblad, A. Mayer, C. Czerkinsky, J. Holmgren, and C. Thivolet. 1997. A cholera toxoidinsulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc. Natl. Acad. Sci. USA 94: 4610-4614.
21. Tarkowski, A., J.-B. Sun, R. Holmdahl, J. Holmgren, and C. Czerkinsky. 1999. Treatment of experimental autoimmune arthritis by nasal administration of a type II collagen-cholera toxoid conjugate vaccine. Arthritis Rheum. 42: 1628-1634.
22. Phipps, P. A., M. R. Stanford, J.-B. Sun, B.-G. Xiao, J. Holmgren, T. Shinnick, A. Hasan, Y. Mizushima, and T. Lehner. 2003. Prevention of mucosally induced uveitis with a HSP60 derived epitope linked to cholera toxin B subunit. Eur. J. Immunol. 33: 224-232.
23. George-Chandy, A., K. Eriksson, M. Lebens, I. Nordstrom, E. Schon, and J. Holmgren. 2001. Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells. Infect. Immun. 69: 5716-5725.
24. + regulatory T cells. Nat. Immunol. 4: 330-336.
25. + mucosal regulatory T cells are induced in gut draining lymphoid tissue within 48 hours after oral antigen application. Eur. J. Immunol. 33: 2801-2810.
26. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172: 5149-5153.
27. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 236-238.
28. - CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc. Natl. Acad. Sci. USA 102: 4091-4096.
29. + T cells mediating skin inflammation. Blood 102: 3295-3301.
30. Holmgren, J. 1981. Actions of cholera toxin and the prevention and treatment of cholera. Nature 292: 413-417.
31. + T cells is mediated by a discrete subset of mesenteric dendritic cells. In 12th International Congress of Mucosal Immunology, Boston, (Abstr. 52734).
32. Lycke, N. 2005. Targeted vaccine adjuvants based on modified cholera toxin. Curr. Mol. Med. 5: 591-597.
33. Elson, C. O., and W. Ealding. 1984. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immunol. 133: 2892-2897.
34. Lavelle, E. C., E. McNeela, M. E. Armstrong, O. Leavy, S. C. Higgins, and K. H. Mills. 2003. Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation. J. Immunol. 171: 2384-2392.
35. + T cells in the normal gut mucosa. J. Immunol. 160: 754-762.
36. Anjuere, F., C. Luci, M. Lebens, D. Rousseau, C. Hervouet, G. Milon, J. Holmgren, C. Ardavin, and C. Czerkinsky. 2004. In vivo adjuvant-induced mobilization and maturation of gut dendritic cells after oral administration of cholera toxin. J. Immunol. 173: 5103-5111.
37. + effector T cells. J. Immunol. 176: 7278-7287.
38. Iwaz, J., E. Kouassi, S. Lafont, and J. P. Revillard. 1990. Elevation of cyclic adenosine monophosphate levels independently down regulates IL-I, IL-2, and IL-2 receptor (CD25) syntheses. Int. J. Immunopharmacol. 12: 631-637.
39. Fontenot, J. D., J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151.
40. + T cells. Immunology 118: 311-320.